ArticleBMC pharmacology & toxicology2026

Population pharmacokinetics of tacrolimus and CYP3A5-driven variability: implications for model-informed dose individualization in pediatric renal transplant recipients.

Lesly Yanira Xajil-Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.